O	0	1	A	A	DT	B-NP
O	2	7	small	small	JJ	I-NP
O	8	15	peptide	peptide	NN	I-NP
O	16	23	derived	derive	VBN	B-VP
O	24	28	from	from	IN	B-PP
O	29	32	Flt	Flt	NN	B-NP
O	32	33	-	-	HYPH	B-NP
O	33	34	1	1	CD	I-NP
O	35	36	(	(	(	O
O	36	41	VEGFR	VEGFR	NN	B-NP
O	41	42	-	-	HYPH	B-NP
O	42	43	1	1	CD	I-NP
O	43	44	)	)	)	O
O	45	54	functions	function	VBZ	B-VP
O	55	57	as	as	IN	B-PP
O	58	60	an	an	DT	B-NP
O	61	71	angiogenic	angiogenic	JJ	I-NP
O	72	81	inhibitor	inhibitor	NN	I-NP
O	81	82	.	.	.	O

O	83	91	Vascular	Vascular	JJ	B-NP
O	92	103	endothelial	endothelial	JJ	I-NP
O	104	110	growth	growth	NN	I-NP
O	111	117	factor	factor	NN	I-NP
O	118	119	(	(	(	O
O	119	123	VEGF	VEGF	NN	B-NP
O	123	124	)	)	)	O
O	125	127	is	be	VBZ	B-VP
O	128	130	an	an	DT	B-NP
O	131	141	angiogenic	angiogenic	JJ	I-NP
O	142	152	stimulator	stimulator	NN	I-NP
O	153	158	which	which	WDT	B-NP
O	159	168	functions	function	VBZ	B-VP
O	169	176	through	through	IN	B-PP
O	177	180	two	two	CD	B-NP
B-Cell	181	192	endothelial	endothelial	JJ	I-NP
O	193	201	specific	specific	JJ	I-NP
O	202	210	tyrosine	tyrosine	NN	I-NP
O	211	217	kinase	kinase	NN	I-NP
O	218	227	receptors	receptor	NNS	I-NP
O	227	228	,	,	,	O
O	229	232	Flt	Flt	NN	B-NP
O	232	233	-	-	HYPH	B-NP
O	233	234	1	1	CD	I-NP
O	235	238	and	and	CC	I-NP
O	239	242	Flk	Flk	NN	I-NP
O	242	243	-	-	HYPH	B-NP
O	243	244	1	1	CD	I-NP
O	244	245	.	.	.	O

O	246	248	In	In	IN	B-PP
O	249	253	this	this	DT	B-NP
O	254	258	work	work	NN	I-NP
O	258	259	,	,	,	O
O	260	262	we	we	PRP	B-NP
O	263	267	show	show	VBP	B-VP
O	268	272	that	that	IN	B-SBAR
O	273	275	an	an	DT	B-NP
O	276	278	11	11	CD	I-NP
O	278	279	-	-	HYPH	I-NP
O	279	284	amino	amino	NN	I-NP
O	285	289	acid	acid	NN	I-NP
O	290	297	peptide	peptide	NN	I-NP
O	298	305	derived	derive	VBN	B-VP
O	306	310	from	from	IN	B-PP
O	311	314	the	the	DT	B-NP
O	315	321	second	second	JJ	I-NP
O	322	336	immunoglobulin	immunoglobulin	NN	I-NP
O	336	337	-	-	HYPH	B-NP
O	337	341	like	like	JJ	I-NP
O	342	348	domain	domain	NN	I-NP
O	349	351	of	of	IN	B-PP
O	352	355	Flt	Flt	NN	B-NP
O	355	356	-	-	HYPH	B-NP
O	356	357	1	1	CD	I-NP
O	358	367	functions	function	NNS	I-NP
O	368	370	as	as	IN	B-PP
O	371	373	an	an	DT	B-NP
O	374	384	angiogenic	angiogenic	JJ	I-NP
O	385	394	inhibitor	inhibitor	NN	I-NP
O	395	397	in	in	IN	B-PP
O	398	403	chick	chick	NN	B-NP
B-Multi-tissue_structure	404	419	chorioallantoic	chorioallantoic	JJ	I-NP
I-Multi-tissue_structure	420	428	membrane	membrane	NN	I-NP
O	429	432	and	and	CC	O
O	433	442	inhibited	inhibit	VBD	B-VP
O	443	447	VEGF	VEGF	NN	B-NP
O	447	448	-	-	HYPH	O
O	448	455	induced	induce	VBN	B-NP
B-Multi-tissue_structure	456	464	vascular	vascular	JJ	I-NP
O	465	477	permeability	permeability	NN	I-NP
O	478	480	in	in	IN	B-PP
O	481	486	Miles	Miles	NNP	B-NP
O	486	487	'	'	POS	B-NP
O	488	493	assay	assay	NN	I-NP
O	494	501	without	without	IN	B-PP
O	502	509	binding	binding	NN	B-NP
O	510	512	to	to	TO	B-PP
O	513	517	VEGF	VEGF	NN	B-NP
O	518	526	directly	directly	RB	B-ADVP
O	526	527	.	.	.	O

O	528	536	Circular	Circular	JJ	B-NP
O	537	546	dichroism	dichroism	NN	I-NP
O	547	550	and	and	CC	O
O	551	558	nuclear	nuclear	JJ	B-NP
O	559	567	magnetic	magnetic	JJ	I-NP
O	568	577	resonance	resonance	NN	I-NP
O	578	586	analyses	analysis	NNS	I-NP
O	587	595	indicate	indicate	VBP	B-VP
O	596	600	that	that	IN	B-SBAR
O	601	605	this	this	DT	B-NP
O	606	613	peptide	peptide	NN	I-NP
O	614	619	forms	form	VBZ	B-VP
O	620	621	a	a	DT	B-NP
O	622	628	stable	stable	JJ	I-NP
O	629	637	extended	extend	VBN	I-NP
O	638	647	structure	structure	NN	I-NP
O	648	650	in	in	IN	B-PP
O	651	659	solution	solution	NN	B-NP
O	659	660	,	,	,	O
O	661	671	presumably	presumably	RB	B-ADVP
O	672	676	beta	beta	SYM	O
O	676	677	-	-	HYPH	O
O	677	682	sheet	sheet	NN	B-NP
O	683	692	structure	structure	NN	I-NP
O	693	696	and	and	CC	O
O	697	699	is	be	VBZ	B-VP
O	700	704	most	most	RBS	B-ADVP
O	705	711	likely	likely	RB	I-ADVP
O	712	720	existing	exist	VBG	B-VP
O	721	723	as	as	IN	B-PP
O	724	725	a	a	DT	B-NP
O	726	731	dimer	dimer	NN	I-NP
O	731	732	.	.	.	O

O	733	736	Our	Our	PRP$	B-NP
O	737	744	results	result	NNS	I-NP
O	745	752	suggest	suggest	VBP	B-VP
O	753	757	that	that	IN	B-SBAR
O	758	762	this	this	DT	B-NP
O	763	768	small	small	JJ	I-NP
O	769	776	peptide	peptide	NN	I-NP
O	777	786	functions	function	VBZ	B-VP
O	787	789	as	as	IN	B-PP
O	790	792	an	an	DT	B-NP
O	793	803	angiogenic	angiogenic	JJ	I-NP
O	804	813	inhibitor	inhibitor	NN	I-NP
O	814	816	by	by	IN	B-PP
O	817	827	inhibiting	inhibit	VBG	B-VP
O	828	832	VEGF	VEGF	NN	B-NP
O	833	841	function	function	NN	I-NP
O	842	849	through	through	IN	B-PP
O	850	851	a	a	DT	B-NP
O	852	855	non	non	AFX	I-NP
O	855	856	-	-	HYPH	I-NP
O	856	860	VEGF	VEGF	NN	I-NP
O	861	868	binding	binding	NN	I-NP
O	869	878	mechanism	mechanism	NN	I-NP
O	878	879	.	.	.	O

